Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of Sacituzumab Govitecan in Chinese Patients With Metastatic Triple-negative Breast Cancer Who Received at Least Two Prior TreatmentsNeoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinomaActive, not recruitingPhase 22026-02-02NCT04454437

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Gilead Sciences180

17 results · Page 1 of 1

Swipe the table sideways for more columns.